Canadian cannabis businesses looking to export into regulated pharmaceutical markets typically need to navigate two related but distinct quality certifications: Good Agricultural and Collection Practices (GACP) and European Good Manufacturing Practices (EU-GMP). GACP establishes the baseline for producing high-quality starting material — covering everything from seed selection and cultivation methods to harvesting, drying, and initial processing. EU-GMP picks up where GACP leaves off, governing the manufacturing, extraction, formulation, and packaging of the finished medicinal product. Most growers and producers pursuing European or other pharmaceutical-grade export markets need to understand both.
This page covers both certifications together: how they relate to one another, what each process involves, the key compliance requirements, and the legal and business implications for Canadian growers and producers.
GACP vs. EU-GMP: How the Two Certifications Fit Together
It's important to understand how GACP and EU-GMP differ, since both are quality standards but apply to different stages of the cannabis production chain. GACP focuses on the agricultural side — the growing and initial harvesting. EU-GMP deals with the manufacturing of the final medicinal product, including extraction, formulation, packaging, and quality control of the finished goods. Think of GACP as the foundation for quality, and EU-GMP as the construction of the final product on that foundation. Achieving GACP can also demonstrate a commitment to quality that facilitates the subsequent pursuit of EU-GMP certification.
It's also worth differentiating both standards from the regulatory frameworks Canadian producers already operate under domestically. In Canada, producers must adhere to Good Production Practices (GPP) under the Cannabis Act, which focus on maintaining a clean facility and ensuring product safety through regular testing. GPP is required for all cannabis producers in Canada, but it doesn't meet the stringent demands of the EU market. The US has its own regulations, often referred to as cGMP, which can differ in focus, sometimes emphasizing end-product testing over process validation. EU-GMP is specifically geared towards pharmaceutical-grade production, requiring meticulous documentation and validation of every step in the manufacturing process.
Here's a quick comparison of how these standards stack up:
| Standard | Focus | Regulatory Authority | Notes |
|---|---|---|---|
| EU-GMP | Pharmaceutical-grade safety and production | EMA + national regulators | Required for medicinal products sold in the EU. |
| GPP | Basic safety and production | Health Canada | Required for all cannabis producers in Canada. |
| US cGMP | Pharmaceutical-grade safety and production | FDA | Not currently required for cannabis at the federal level in the US. |
| GACP | Basic safety and cleanliness pre-production | Country dependent | Focuses on the quality of raw materials (e.g., cultivation). |
Within the European Union, cannabis is treated as a medicinal product. This classification is key to understanding why EU-GMP certification is non-negotiable for market access. Any product intended for medicinal use within the EU must comply with EU-GMP guidelines — even if your cannabis is cultivated in Canada, to be sold as a medicinal product in the EU it must ultimately be manufactured in an EU-GMP-certified facility. Growers who only need to supply raw material to a licensed EU-GMP processor, rather than manufacture finished product themselves, may only need GACP.
GACP Certification: Growing and Harvesting Standards
Good Agricultural and Collection Practices, or GACP, is a set of guidelines focused on the cultivation and harvesting of medicinal plants. For Canadian cannabis growers aiming for certification, GACP establishes the baseline for producing high-quality starting materials, covering everything from seed selection and cultivation methods to harvesting, drying, and initial processing. The core idea is to ensure that the cannabis grown is safe, consistent, and free from contaminants — growing plants with a specific purpose and quality in mind, setting the stage for further pharmaceutical processing.
In Canada, GACP certification for medicinal cannabis specifically addresses the agricultural and primary collection aspects of production — the cultivation of cannabis plants and the initial steps taken after harvest, such as drying and trimming. It's about controlling the environment, the inputs, and the processes to guarantee the quality and safety of the raw cannabis material. This certification is particularly important for growers who intend to supply their product to licensed processors who will then use it to create finished medicinal products. It may also allow you to use certain certification badges to promote your brand.
The GACP Certification Process
Getting GACP certified involves a structured approach, broken down into distinct stages designed to thoroughly evaluate your operations and confirm adherence to Good Agricultural and Collection Practices.
Preliminary Stage — Application Review and Audit Scheduling: The first step is submitting your application to the chosen certification body, giving them an overview of your operation. They will review it to determine the scope of your cultivation, the size of your facility, and any specific complexities, then assemble the right team of auditors and schedule the audit dates. It's important to be thorough and accurate in your application to avoid delays.
Stage I Audit — Quality System and Preparedness Evaluation: This initial audit is often conducted remotely or as a preliminary on-site visit. Auditors will look closely at your quality management system, checking for the necessary documentation, policies, and procedures, and review how your system aligns with applicable Canadian regulations. The goal is to confirm your quality system has been properly set up and is being applied according to GACP standards.
Stage II Audit — On-Site Inspection and Findings Documentation: This is a detailed, on-site inspection of your cultivation and primary processing activities. Auditors observe your operations firsthand, checking for compliance with the GACP standard and documenting any non-conformances. If any are found, you'll need to develop and implement a corrective action plan. Once everything is satisfactory, a final report is prepared and submitted to the certification body, leading to the potential issuance of your GACP certificate.
Key Elements for GACP Compliance
Achieving GACP certification involves paying close attention to several core areas within your cannabis cultivation operation:
- Controlled environment cultivation: Your facility — indoor setup or greenhouse — must have systems in place to manage temperature, humidity, light, and air quality, minimizing risks from pests, diseases, and environmental fluctuations at every stage from propagation to harvest.
- Comprehensive record-keeping: Detailed records covering propagation (parent plants, seed sources, rooting times), cultivation (nutrient use, watering, pest and disease management, environmental controls), harvesting (dates, times, methods), and post-harvest handling (drying conditions, curing times, processing steps) — allowing full traceability.
- Procurement to transportation: Documented procedures for selecting and approving suppliers of seeds and propagating material, proper handling and storage of harvested material, controlled primary processing (drying, trimming), and controlled packaging and transportation to maintain product integrity.
Maintaining quality throughout the entire supply chain, from the moment you acquire your starting materials to when the product leaves your facility, is what GACP certification is all about — demonstrating a commitment to producing a safe and reliable product for consumers and pharmaceutical partners alike.
Benefits of GACP Certification
GACP certification provides a structured way to make sure your cannabis is consistently good and safe, preventing contamination and ensuring crops are grown and processed in a controlled manner. For Canadian growers looking to expand beyond domestic sales, it can be key to accessing international pharmaceutical markets — many of which, especially those in Europe, have strict requirements for cannabis used in medicines, and often require this level of assurance before considering a supplier. Specific advantages include:
- Consistent quality: GACP helps maintain uniformity in your crops and products.
- Reduced risk: It minimizes the chances of product recalls or safety issues.
- Market recognition: It signals adherence to international quality benchmarks and builds credibility with partners, buyers, and consumers.
Preparing Your Facility for a GACP Audit
Getting ready for a GACP audit means having systems in place that show you're serious about quality and consistency, not just a clean grow room. A strong quality management system (QMS) is the backbone of GACP compliance — defining your quality policy, establishing measurable quality objectives, documenting every step of cultivation, harvesting, and initial processing, implementing controls, and managing records from seed to sale.
Auditors will also want proof that your equipment works as intended and that your processes are reliable — for example, documentation showing lighting systems have been tested and perform within specified parameters, and that environmental controls (temperature, humidity, CO2 levels) are monitored and validated on an ongoing basis. Finally, Standard Operating Procedures (SOPs) need to be clear, concise, and cover every critical activity: cultivation, harvesting (including drying and curing), hygiene and sanitation, and record-keeping.
EU-GMP Certification: Manufacturing and Processing Standards
For Canadian cannabis producers looking to tap into the European market, EU-GMP certification is a significant step — the gold standard for medicinal products sold within the European Union. This certification assures that your cannabis products are manufactured to the highest pharmaceutical standards, focusing heavily on the consistency and repeatability of your production processes. While not all markets currently mandate this level of certification for cannabis, the trend is moving towards stricter quality controls, and having EU-GMP certification can provide a substantial competitive edge and unlock access to lucrative export opportunities.
The EU-GMP Certification Process
Getting EU-GMP certification for your Canadian cannabis products is a structured journey. While the exact order might vary slightly depending on the specific EU member state's regulatory body, the core components remain consistent. It's wise to engage with your local Canadian regulatory authority early on to understand their perspective and any specific requirements for facilities seeking international certifications. A general breakdown of the process:
- Initial Assessment and Planning: A thorough review of your existing processes, facilities, and documentation against EU-GMP requirements.
- Gap Analysis: Identifying the differences between your current practices and what EU-GMP demands.
- Remediation and Implementation: Making the necessary changes — updating equipment, revising SOPs, retraining staff, or improving facility layout and controls.
- Documentation and Validation: Meticulously documenting all changes and processes, including validating that they consistently produce the desired results.
- Pre-Audit Preparations: Conducting internal audits to simulate the real thing and catch last-minute issues.
- Third-Party Audit: An accredited inspection body conducts a formal audit of your facility and operations.
- Certification: If the audit is successful, EU-GMP certification is granted.
The gap analysis is your first major step — a detailed look at your current operations compared to the EU-GMP guidelines that highlights areas that don't meet the stringent requirements for pharmaceutical-grade production. This phase is critical because it directly addresses the deficiencies that would prevent certification, and remediation (the practical work of bringing your facility and processes up to standard) should be budgeted accordingly in both time and resources.
After remediation, an independent, accredited third-party auditor will meticulously review your documentation, observe your processes, and interview your staff to verify compliance. If your facility passes, you'll be officially recognized with EU-GMP certification — though this isn't a one-time achievement, as regular inspections follow to ensure continued compliance.
Key Requirements for EU-GMP Compliance
Achieving EU-GMP certification means demonstrating control and consistency throughout your entire production chain, not just having a clean facility. At its core, EU-GMP certification hinges on proving that your production methods are robust and can be repeated with predictable outcomes — meticulously documenting every step from cultivation and harvesting to extraction and final packaging, and showing that you can consistently produce a product that meets predefined specifications.
Producing cannabis for the EU market under EU-GMP also requires implementing a comprehensive Quality Management System (QMS) covering rigorous testing for contaminants, ensuring the absence of harmful substances, and maintaining strict environmental controls — to guarantee the final product is safe for patient use. Documentation is the backbone of this compliance: detailed SOPs for every task, plus meticulous records including batch records, equipment logs, training records, and any deviations from standard procedures, allowing full traceability from seed to sale.
Timeline and Factors Influencing EU-GMP Attainment
The time it takes to achieve EU-GMP certification can vary quite a bit — generally anywhere from a few months to a couple of years. This depends on how much work is needed to close the gaps identified in your gap analysis, the availability of the regulatory authorities conducting inspections, and how many issues are found during inspections and how quickly they're fixed.
| Factor | Potential Impact on Timeline |
|---|---|
| Gap Analysis Completion | Significant (weeks to months) |
| Regulatory Authority Backlog | Moderate (weeks to months) |
| Number of Non-Compliances | High (weeks to months per issue) |
| Remediation Speed | High (weeks to months) |
| Scope of Certification | Moderate (can shorten) |
There are ways to potentially speed things up: focusing certification on specific areas or product lines intended for the EU market, using equipment already familiar to EU regulators, and paying close attention to detail in documentation and operations to avoid avoidable delays. Working with professionals who have a proven track record in EU-GMP certification is highly recommended — they understand the nuances of the regulations, can help identify potential issues before they become major problems, and can streamline communication with regulatory bodies.
Legal and Regulatory Considerations for Canadian Cannabis Exporters
Alignment with Canadian Cannabis Regulations
For Canadian cannabis growers and producers pursuing GACP or EU-GMP certification, understanding and adhering to the existing national framework is the first step. Health Canada oversees the production, distribution, and sale of cannabis through the Cannabis Act and its associated Regulations, particularly Part 5 concerning Good Production Practices (GPP), which lays the groundwork for quality and safety standards. While GACP and EU-GMP are international standards, their principles often align with or complement Canadian GPP requirements. Ensuring your cultivation and processing activities meet or exceed Health Canada's standards is paramount before even considering international certification — failure to comply with Canadian regulations can result in serious consequences, including licence suspension or revocation, and significant fines.
Meeting International Pharmaceutical and Export Market Demands
GACP and EU-GMP certification are often stepping stones for Canadian growers and producers looking to access international markets, especially those with established medical cannabis programs. If your goal is to sell cannabis products in the European Union, EU-GMP certification is not optional — without it, your products simply cannot be legally sold in EU member states. Achieving GACP first can demonstrate a commitment to quality that facilitates the subsequent pursuit of EU-GMP certification, opening doors to supplying pharmaceutical companies abroad who often demand a higher level of quality assurance than domestic markets require.
Competitive Advantages and Future-Proofing Your Operations
Even in markets where these certifications aren't strictly mandated, holding them provides a distinct competitive edge — signalling to potential business partners, distributors, and consumers that your operation prioritizes pharmaceutical-grade quality and safety, and differentiating you from competitors who may only meet basic GPP standards. The global regulatory landscape for cannabis is constantly evolving, and many industry observers anticipate that stricter quality and safety standards, similar to GMP, will become the norm as legalization progresses in other countries. Pursuing GACP and EU-GMP certification now can get Canadian companies ahead of potential future requirements, making operations more adaptable and resilient.
The Role of Legal Counsel
Navigating the legal landscape of cannabis production and international certification can be complex. Engaging legal counsel with expertise in Canadian cannabis law and international trade is highly advisable — they can help interpret the nuances of both domestic regulations and the specific requirements of target international markets, assist in drafting and reviewing contracts with international partners, ensure compliance with import/export permits, and advise on intellectual property matters. A good legal advisor can help prevent costly mistakes and ensure your GACP or EU-GMP certification journey is legally sound, while also providing guidance on how these certifications interact with your existing Canadian licensing and compliance obligations.
Navigating the rules for Canadian growers and producers can feel like a maze. Understanding the legal and regulatory landscape is critical for your business to grow smoothly — contact Substance Law to discuss your GACP or EU-GMP certification strategy.
Frequently Asked Questions
What is GACP certification?
GACP stands for Good Agricultural and Collection Practices — a set of guidelines designed to make sure plants grown for medicine, like cannabis, are handled with care from the moment they're planted through to when they're harvested and dried. It's about ensuring the quality and safety of plant materials before they're used for making medicines.
What is EU-GMP certification?
EU-GMP stands for European Good Manufacturing Practices — a stamp of approval showing a company follows strict rules for manufacturing products, especially medicines. For Canadian cannabis businesses, this certification is essential to sell products in European countries, telling regulators and customers the cannabis is manufactured safely and to pharmaceutical-grade quality.
How do GACP and EU-GMP differ?
GACP covers the growing and initial handling of the plant material — everything up to drying. EU-GMP takes over from there, covering the processing, extraction, and packaging of the final medicinal product. They work together: GACP ensures good raw material, and EU-GMP ensures a good finished product. Canada's own Good Production Practices (GPP) sit alongside both as the baseline domestic standard, while the US's cGMP is broadly comparable to EU-GMP but focuses more on end-product testing.
What are the main steps to get GACP certified?
The process starts with an application and paperwork review, followed by a Stage I audit of your quality systems and a Stage II on-site inspection to confirm your practices match the GACP standard. Any non-conformances found need to be corrected before a final report leads to certification.
What are the main steps to get EU-GMP certified?
Canadian companies first need a gap analysis to identify where current operations fall short of EU-GMP requirements. They then remediate those gaps — changing processes, upgrading equipment, or training staff — before an accredited third-party auditor inspects the facility. If the audit passes, certification is granted.
How long does EU-GMP certification take, and can the process be sped up?
Generally anywhere from a few months to a couple of years, depending on how much work is needed to close compliance gaps and how busy the inspecting authorities are. Companies can speed things up by scoping certification to only the product lines intended for EU export, using equipment already approved in Europe, and working with experienced consultants who know the process well.
Can any cannabis farm get GACP certified?
GACP certification is mainly for cannabis grown in controlled environments, like greenhouses or indoor facilities. Outdoor growing or temporary setups usually don't meet the strict requirements needed to guarantee consistent quality and safety for medicinal use.
What are the biggest benefits of holding GACP and EU-GMP certification?
Better product quality and safety, which builds trust with buyers and pharmaceutical partners; access to international markets with strict quality requirements, particularly in Europe; and a more credible, competitive position in the marketplace. Holding both certifications also helps future-proof your operations against stricter regulations that are increasingly expected to spread to other markets, including Canada and the US.
